Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Fortress Biotech Q1 2024 GAAP EPS $(1.03) Beats $(1.73) Estimate, Sales $13.030M Miss $14.131M Estimate

Author: Benzinga Newsdesk | May 15, 2024 04:53pm

Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.73) by 40.46 percent. The company reported quarterly sales of $13.030 million which missed the analyst consensus estimate of $14.131 million by 7.79 percent. This is a 4.84 percent increase over sales of $12.429 million the same period last year.

Posted In: FBIO